ÂÜÀòÂÒÂ×

Scott Boyer is a co-founder of Klaria. As Chief Scientific Officer, Scott Boyer oversees research, clinical development and regulatory affairs. Prior to joining Klaria, he was Chief Scientist at AstraZeneca with global responsibility for molecular and investigational toxicology across Astra Zeneca and he was a member of the AZ senior management team. Prior to that, he was Senior Research Scientist at Pfizer. Scott Boyer has a Ph.D from the University of Colorado, Boulder in Molecular Toxicology. He completed a NIH Fogarty International Center Postdoctoral Fellowship at the Karolinska Institute. Scott Boyer owns 731 042 shares in Klaria Pharma.